THE DUBERSTEIN GROUP INC. for SANOFI-AVENTIS U.S. INC.
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Copyright/Patent/Trademark CPT
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Health Issues HCR
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Medicare/Medicaid MMM
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Budget/Appropriations BUD
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Chemicals/Chemical Industry CHM
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Animals ANI
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Medical/Disease Research/Clinical Labs MED
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Advertising ADV
FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN New | — |
| STEVEN CHAMPLIN New | — |
| KENNETH DUBERSTEIN New | — |
| BRIAN GRIFFIN New | Sr. Ldrship Advisor, Sen. Dorgan |
| ERIC UELAND New | PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SANOFI-AVENTIS SA | France | France | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.